mRNA cancer vaccine granted world-first approval
European Pharmaceutical Review
MAY 10, 2024
The US Food and Drug Administration (FDA) has granted the first approval of an Epstein–Barr virus-related mRNA therapeutic cancer vaccine. WGc-043 demonstrated “superior safety and efficacy compared to other publicly available mRNA therapeutic cancer vaccines”, WestGene explained. billion by 2029.
Let's personalize your content